Periconceptional exposure to efavirenz and neural tube defects.
De Santis
Marco
M
Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy. marco.desantis15@tin.it
Carducci
Brigida
B
De Santis
Lidia
L
Cavaliere
Anna Franca
AF
Straface
Gianluca
G
D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D048588:Benzoxazines; D003521:Cyclopropanes; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D009436:Neural Tube Defects / Q000139:chemically induced* / Q000175:diagnosis; D010078:Oxazines / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000188:drug therapy*; D011256:Pregnancy Outcome; D018570:Risk Assessment
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; C098320:efavirenz